You have 9 free searches left this month | for more free features.

Unfit to intensive chemotherapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

Recruiting
  • AML, Adult
  • Chicago, Illinois
  • +1 more
Aug 17, 2022

Acute Myeloid Leukemia Trial in Firenze (Venetoclax+Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Firenze, Italy
    Az. Ospedaliero - Universitaria Careggi
Jan 3, 2022

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax)

Completed
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Nov 7, 2022

MDS, Acute Myeloid Leukemia Trial in France (BST-236)

Recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Amiens, France
  • +16 more
Jan 2, 2023

AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

Recruiting
  • AML, Adult
  • +3 more
  • Shreveport, Louisiana
  • +3 more
Jul 19, 2022

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)

Terminated
  • ACUTE MYELOID LEUKEMIA
  • New Haven, Connecticut
    Yale Cancer Center/Smilow
Sep 18, 2021

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

Acute Myeloid Leukemia Trial in France (GRASPA)

Completed
  • Acute Myeloid Leukemia
  • Nice, Alpes Maritimes, France
  • +20 more
Feb 18, 2022

NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

Recruiting
  • NSCLC, Stage III
  • Durvalumab Injection [Imfinzi]
  • +2 more
  • Aachen, Germany
  • +13 more
Nov 29, 2022

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Venetoclax plus Azacitidine
    • standard of care chemotherapy plus gemtuzumab ozogamicin
    • Essen, NRW, Germany
    • +17 more
    Jun 6, 2023

    Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +27 more
    Jan 20, 2023

    Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Sep 18, 2023

    Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Neoplasm
    • (no location specified)
    Apr 24, 2023

    Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive

    Unknown status
    • Acute Myeloid Leukemia, in Relapsed or Refractory
    • +2 more
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Sep 8, 2020

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)

    Recruiting
    • Pancreatic Cancer Non-resectable
    • stereotactic ablative radiotherapy
    • Amsterdam, Noord-Holland, Netherlands
    • +1 more
    Feb 22, 2022

    Unfit AML Patients Treated With Combination Venetoclax Plus

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax plus HMA
    • Bergamo, Italy
    • +22 more
    Oct 10, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Greenwich, Connecticut
    • +27 more
    Dec 30, 2022

    Penile Cancer, Advanced Cancer, Metastatic Cancer Trial in Toronto (Avelumab, Best Supportive Care)

    Recruiting
    • Penile Cancer
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Nov 26, 2021

    Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

    Recruiting
    • Acute Monocytic Leukemia
    • Newly Diagnosed
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Oct 3, 2022

    Locally Advanced Lung Non-Small Cell Carcinoma Trial in Terni (Stereotactic Ablative Radiotherapy in Unresectable Locally

    Completed
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • Stereotactic Ablative Radiotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
    • Terni, TR, Italy
      Radiotherapy Oncology Centre "S.Maria" Hospital
    Mar 22, 2022